

Adial Pharmaceuticals completes AD04 demo batch, validating process transfer and enabling Phase 3 production and FDA IND updates.
You can purchase shares of Adial Pharmaceuticals Inc (NASDAQ:ADIL) through any online brokerage.
Other companies in Adial Pharmaceuticals Inc’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Adial Pharmaceuticals Inc has a consensus price target of $18.17.
The stock price for Adial Pharmaceuticals Inc (NASDAQ: ADIL) is $4.86 last updated October 28, 2026 at 7:52 PM EDT.
There are no upcoming dividends for Adial Pharmaceuticals Inc.
Adial Pharmaceuticals Inc does not have any upcoming earnings scheduled.
There is no upcoming split for Adial Pharmaceuticals Inc.
Adial Pharmaceuticals Inc is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.